Daphne Zohar: Giving life to science
Daphne Zohar, Founder and CEO of Seaport Therapeutics, shared a post on LinkedIn:
“We have some news today! Seaport Therapeutics is launching with an oversubscribed $100M in financing. I’m excited to take the helm of Seaport and to work with my Karuna co-founder Steven Paul again, together with a stellar team and syndicate (ARCH Venture Partners, Third Rock Ventures and PureTech) as we chart a proven path to help patients living with neuropsychiatric disorders. As I pass the baton to PureTech’s new CEO – my good colleague Bharatt Chowrira – I reflect on the rewarding journey I’ve had in founding PureTech and all of the amazing people that have been part of that journey in this video.”
Additional information.
Proceed to the video attached to the post.
Source: Daphne Zohar/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023